Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Janssen-Cilag Pty Ltd
Scientific Title
A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations